4//SEC Filing
Miller Joseph M 4
Accession 0001062993-22-000244
CIK 0001534120other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:25 PM ET
Size
5.2 KB
Accession
0001062993-22-000244
Insider Transaction Report
Form 4
Miller Joseph M
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-31+8,920→ 8,920 totalExercise: $1.70From: 2021-12-31Exp: 2031-12-31→ Common Stock (8,920 underlying)
Footnotes (1)
- [F1]100% of this stock option will immediately vest on the date that it is granted.
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001746372
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:25 PM ET
- Size
- 5.2 KB